Runa Watkins

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

8h-index586citations37works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(14), Inflammatory Bowel Disease(7), COVID-19 Clinical Research Studies(6), Celiac Disease Research and Management(6), Vaccine Coverage and Hesitancy(5)

Publications37 total

Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease
UNC Libraries·2025Open Access
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases
UNC Libraries·2025Open Access
Congenital Diarrhea and Enteropathies
NeoReviews·2025· 1 cited
Long-Term Effectiveness and Durability of COVID-19 Vaccination among Patients with Inflammatory Bowel Disease
UNC Libraries·2025Open Access
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease
Inflammatory Bowel Diseases·2024· 1 citedOpen Access
S4513 Nodular Regenerative Hyperplasia in Pediatric Transaminitis
The American Journal of Gastroenterology·2024
Tu1843 LONG-TERM EFFECTIVENESS AND DURABILITY OF SARS-COV-2 VACCINATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Gastroenterology·2024
Tu1844 MAGNITUDE OF SARS-COV-2 SPIKE ANTIBODY LEVEL FOLLOWING VACCINATION IS NOT ASSOCIATED WITH RISK OF DEVELOPING SYMPTOMATIC COVID-19 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Gastroenterology·2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease
Clinical Gastroenterology and Hepatology·2024· 4 cited
Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease
Journal of Pediatric Gastroenterology and Nutrition·2024Open Access
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease
UNC Libraries·2023Open Access
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease
UNC Libraries·2023Open Access
Asymptomatic Esophageal Eosinophilia in an 11‐Year‐Old with Severe Persistent Asthma
Case Reports in Pediatrics·2023· 1 citedOpen Access
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID
UNC Libraries·2022Open Access
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease
The American Journal of Gastroenterology·2022· 14 cited
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases·2022· 8 citedOpen Access
Myelolipoma After Infliximab Treatment for Crohn's Disease
ACG Case Reports Journal·2022· 1 citedOpen Access
Su1492: STRONG HUMORAL IMMUNE RESPONSE TO SARS-COV-2 VACCINE ADDITIONAL DOSE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES
Gastroenterology·2022Open Access
Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases
Clinical Gastroenterology and Hepatology·2022· 36 citedOpen Access
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases
The American Journal of Gastroenterology·2021· 44 cited
page 1 of 2Next →

Frequent Co-authors

Jeremy Adler(19), Athos Bousvaros(19), Meenakshi Bewtra(19), Emanuelle Bellaguarda(18), Francis A. Farraye(18), Ann M. Firestine(18), Kimberly N. Weaver(17), Marla C. Dubinsky(17), Arthur Kastl(17), Michael D. Kappelman(17), Millie D. Long(17), Ryan C. Ungaro(16), Xiangfeng Dai(15), Kelly Chun(15), Michael Zikry(15), Xian Zhang(13), Margie Boccieri(13), Raymond K. Cross(10), Peter Higgins(10), Riley Craig(9)